2027 Drug Hypersensitivity Research Grant
The 2027 Drug Hypersensitivity Research Grant funds innovative research on drug allergy mechanisms, diagnosis, and management, advancing the science of drug hypersensitivity.
Browse similar grants
Funder: American Academy of Allergy Asthma and Immunolog
Due Dates: August 12, 2026: Letter of Intent Closes | October 12, 2026: Application deadline | October 27, 2026: Full Application Closes
Funding Amounts: $50,000–$150,000 total direct costs per award over 2 years (up to three awards); no indirect costs allowed.
Summary: Supports innovative research projects advancing knowledge and novel approaches in drug hypersensitivity (excluding vaccine reactions).
Key Information: Full proposals are by invitation only after LOI; applicants must be AAAAI members and early-career faculty.
Description
This opportunity supports up to three research projects focused on advancing the understanding, diagnosis, and management of drug hypersensitivity. The grant encourages the development of novel techniques, agents, methodologies, models, or applications that can significantly impact drug allergy research. Projects related to vaccine reactions are not eligible. The program specifically aims to foster groundbreaking work and career development among early-career investigators in the field of allergy and immunology.
